The Global Systemic Scleroderma Treatment Market was valued at $1.80 Billion in 2020. Growing at a high CAGR of more than 8.06% between 2021 and 2031, it is estimated to reach $4.3 Billion by 2031. Systemic Scleroderma, also known as systemic sclerosis, is a chronic autoimmune disease characterized by thickening and hardening of the skin, as well as internal organ...